Back
Open Access

Factor XI inhibition uncoupled: mechanistic insights and rationale

Session: Advances in thrombosis management: evaluating current and emerging anticoagulation strategies
Topic: Thrombosis, Platelets, and Coagulation
Speaker: Doctor J. Weitz (Hamilton, CA)
Sponsored by Medscape - Supported by an unrestricted educational grant from the Bristol Myers Squibb and Johnson & Johnson Innovative Medicine Alliance
Event: ESC Congress 2024

Congress Presentation

Add to my library

Like

About the speaker

Doctor Jeffrey Weitz

Thrombosis & Atherosclerosis Research Institute (TaARI), Hamilton (Canada)
33 presentations
1 follower

4 more presentations in this session

Welcome and Introductions

Speaker: Professor V. Kunadian (Newcastle-Upon-Tyne, GB)

Access
Slides
Video
Like
Thumbnail

Contemporary thrombosis management -- state of the state

Speaker: Professor V. Kunadian (Newcastle-Upon-Tyne, GB)

Access
Slides
Video
Like
Thumbnail

Factor XI inhibition: clinical view on current research and future implications

Speaker: Professor C. Lam (Singapore, SG)

Access
Slides
Video
Like
Thumbnail

Program summary and conclusion

Speaker: Professor V. Kunadian (Newcastle-Upon-Tyne, GB)

Access
Slides
Video
Like
Thumbnail

Access the full session

Advances in thrombosis management: evaluating current and emerging anticoagulation strategies

Speakers: Doctor J. Weitz, Professor V. Kunadian, Professor V. Kunadian, Professor C. Lam, Professor V. Kunadian
Access
Video
Like
Thumbnail

About the event

Image

ESC Congress 2024

30 August - 2 September 2024

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

bristol-myers-squibb Explore sponsored resources
novartis Explore sponsored resources